Identification of novel diagnostic biomarkers for deep venous thrombosis
(2018) In British Journal of Haematology 181(3). p.378-385- Abstract
The combination of a negative D-dimer and a Wells score can rule out, but not confirm, a diagnosis of deep venous thrombosis (DVT). We aimed to identify new diagnostic biomarkers for DVT and to investigate their relationship with hypercoagulability markers [D-dimer and activated protein C-protein C inhibitor (APC-PCI) complex]. We screened 92 cardiovascular-specific proteins in plasma samples from 45 confirmed DVT patients and 45 age- and sex-matched non-DVT patients selected from a prospective multicentre diagnostic management study (SCORE) by Proseek Multiplex CVDIII96×96. Plasma levels of 30 proteins were significantly different between DVT and non-DVT patients. After Bonferroni correction, plasma levels of seven proteins:... (More)
The combination of a negative D-dimer and a Wells score can rule out, but not confirm, a diagnosis of deep venous thrombosis (DVT). We aimed to identify new diagnostic biomarkers for DVT and to investigate their relationship with hypercoagulability markers [D-dimer and activated protein C-protein C inhibitor (APC-PCI) complex]. We screened 92 cardiovascular-specific proteins in plasma samples from 45 confirmed DVT patients and 45 age- and sex-matched non-DVT patients selected from a prospective multicentre diagnostic management study (SCORE) by Proseek Multiplex CVDIII96×96. Plasma levels of 30 proteins were significantly different between DVT and non-DVT patients. After Bonferroni correction, plasma levels of seven proteins: P-selectin, transferrin receptor protein 1, von Willebrand factor, tissue factor pathway inhibitor, osteopontin (OPN), bleomycin hydrolase and ST2 protein remained significantly different. The area under curve (AUC) for these proteins ranged from 0·70 to 0·84. Furthermore, all seven identified proteins were significantly associated with markers of hypercoagulability. A combination of OPN and APC-PCI had the best ability to discriminate DVT from non-DVT patients (AUC = 0·94; sensitivity = 89% and specificity = s84%). In conclusion, we identified multiple proteins associated with markers of hypercoagulability and with a potential to become novel diagnostic biomarkers for DVT.
(Less)
- author
- Memon, Ashfaque A. LU ; Sundquist, Kristina LU ; PirouziFard, Mirnabi LU ; Elf, Johan L. LU ; Strandberg, Karin LU ; Svensson, Peter J. LU ; Sundquist, Jan LU and Zöller, Bengt LU
- organization
-
- Family Medicine and Clinical Epidemiology (research group)
- Family Medicine, Cardiovascular Epidemiology and Lifestyle (research group)
- EpiHealth: Epidemiology for Health
- Vascular Diseases - Clinical Research (research group)
- Clinical Chemistry, Malmö (research group)
- Clinical Coagulation, Malmö (research group)
- publishing date
- 2018-05-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- APC-PCI, coagulation, D-dimer, deep venous thrombosis, diagnostic biomarkers
- in
- British Journal of Haematology
- volume
- 181
- issue
- 3
- pages
- 8 pages
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:29672822
- scopus:85045892663
- ISSN
- 0007-1048
- DOI
- 10.1111/bjh.15206
- project
- Identification of diagnostic and prognostic biomarkers of venous thromboembolism and its recurrence
- Genetic risk factor of venous thromboembolism and its recurrence
- language
- English
- LU publication?
- yes
- id
- 76cdd5a0-603e-4665-853e-1f1fb06113bd
- date added to LUP
- 2018-05-04 07:51:50
- date last changed
- 2024-09-16 21:16:26
@article{76cdd5a0-603e-4665-853e-1f1fb06113bd, abstract = {{<p>The combination of a negative D-dimer and a Wells score can rule out, but not confirm, a diagnosis of deep venous thrombosis (DVT). We aimed to identify new diagnostic biomarkers for DVT and to investigate their relationship with hypercoagulability markers [D-dimer and activated protein C-protein C inhibitor (APC-PCI) complex]. We screened 92 cardiovascular-specific proteins in plasma samples from 45 confirmed DVT patients and 45 age- and sex-matched non-DVT patients selected from a prospective multicentre diagnostic management study (SCORE) by Proseek Multiplex CVDIII<sup>96×96</sup>. Plasma levels of 30 proteins were significantly different between DVT and non-DVT patients. After Bonferroni correction, plasma levels of seven proteins: P-selectin, transferrin receptor protein 1, von Willebrand factor, tissue factor pathway inhibitor, osteopontin (OPN), bleomycin hydrolase and ST2 protein remained significantly different. The area under curve (AUC) for these proteins ranged from 0·70 to 0·84. Furthermore, all seven identified proteins were significantly associated with markers of hypercoagulability. A combination of OPN and APC-PCI had the best ability to discriminate DVT from non-DVT patients (AUC = 0·94; sensitivity = 89% and specificity = s84%). In conclusion, we identified multiple proteins associated with markers of hypercoagulability and with a potential to become novel diagnostic biomarkers for DVT.</p>}}, author = {{Memon, Ashfaque A. and Sundquist, Kristina and PirouziFard, Mirnabi and Elf, Johan L. and Strandberg, Karin and Svensson, Peter J. and Sundquist, Jan and Zöller, Bengt}}, issn = {{0007-1048}}, keywords = {{APC-PCI; coagulation; D-dimer; deep venous thrombosis; diagnostic biomarkers}}, language = {{eng}}, month = {{05}}, number = {{3}}, pages = {{378--385}}, publisher = {{Wiley-Blackwell}}, series = {{British Journal of Haematology}}, title = {{Identification of novel diagnostic biomarkers for deep venous thrombosis}}, url = {{http://dx.doi.org/10.1111/bjh.15206}}, doi = {{10.1111/bjh.15206}}, volume = {{181}}, year = {{2018}}, }